Medical Xpress January 24, 2022
Massachusetts Institute of Technology

The COVID-19 pandemic sent shockwaves through the life science ecosystem, uniting the scientific community with a common purpose and reimagining pathways to address global health challenges.

To help accelerate that innovation, the MIT Center for Collective Intelligence, the MIT Media Lab’s Community Biotechnology Initiative, and MilliporeSigma—the U.S. and Canadian life science business of Merck KGaA, Darmstadt, Germany—together convened more than 200 thought leaders from around the world to collaboratively capture the disruptions caused by the , and identify the solutions that will help usher in the future of the life sciences.

A comprehensive report containing synthesized, data-driven insights from this expert group, known as the “Life Sciences Supermind,” has now been published. The work builds on the collaborators’ research from...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma / Biotech
Akiko Iwasaki: The Immunology of Covid and the Future
Novartis to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75B
GLP-1 Agonists May One Day Treat Prostate Cancer
Amgen shares soar as executives outline obesity drug push
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders

Share This Article